Clinton A White

Summary

Affiliation: Baylor College of Medicine
Country: USA

Publications

  1. ncbi Nitazoxanide: a new broad spectrum antiparasitic agent
    Clinton A White
    American College of Physicians and Infectious Disease Section, Department of Medicine, Baylor College of Medicine, One Baylor Plaza, 535EA Houston, TX 77030, USA
    Expert Rev Anti Infect Ther 2:43-9. 2004
  2. ncbi Infections in Hispanic immigrants
    A Clinton White Jr
    Infectious Disease Section, Department of Medicine, Baylor College of Medicine and Ben Taub General Hospital, Houston, TX, 77030, USA
    Clin Infect Dis 34:1627-32. 2002
  3. ncbi Interferon-gamma expression in jejunal biopsies in experimental human cryptosporidiosis correlates with prior sensitization and control of oocyst excretion
    A C White
    Infectious Diseases Section, Dept of Medicine, Baylor College of Medicine, Houston, TX 77030
    J Infect Dis 181:701-9. 2000
  4. ncbi Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management
    A C White
    Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA
    Annu Rev Med 51:187-206. 2000
  5. ncbi Expression of IL-15 and IL-4 in IFN-gamma-independent control of experimental human Cryptosporidium parvum infection
    P Robinson
    Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA
    Cytokine 15:39-46. 2001
  6. ncbi Determinants of sustained virological suppression in indigent, HIV-infected patients: is single protease inhibitor-based antiretroviral therapy truly highly active?
    F Visnegarwala
    Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA
    HIV Clin Trials 5:117-24. 2004
  7. ncbi Management of neurocysticercosis
    Terrence Riley
    Department of Neurology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA
    CNS Drugs 17:577-91. 2003
  8. ncbi Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoid
    W A Keitel
    Department of Microbiology and Immunology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
    Vaccine 18:531-9. 1999
  9. ncbi Is there a race-based disparity in the survival of veterans with HIV?
    Thomas P Giordano
    Department of Medicine, Baylor College of Medicine, Houston, TX, USA
    J Gen Intern Med 21:613-7. 2006
  10. ncbi ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results
    R L Murphy
    Department of Medicine, Northwestern University, Chicago, IL 60611, USA
    AIDS 15:F1-9. 2001

Collaborators

Detail Information

Publications11

  1. ncbi Nitazoxanide: a new broad spectrum antiparasitic agent
    Clinton A White
    American College of Physicians and Infectious Disease Section, Department of Medicine, Baylor College of Medicine, One Baylor Plaza, 535EA Houston, TX 77030, USA
    Expert Rev Anti Infect Ther 2:43-9. 2004
    ..Nitazoxanide is the first agent proven to be effective in cryptosporidiosis. It has also proven efficacy in giardiasis. Nitazoxanide is efficacious again intestinal helminths. Additional indications may be developed in the future...
  2. ncbi Infections in Hispanic immigrants
    A Clinton White Jr
    Infectious Disease Section, Department of Medicine, Baylor College of Medicine and Ben Taub General Hospital, Houston, TX, 77030, USA
    Clin Infect Dis 34:1627-32. 2002
    ..When included in the differential diagnosis, most of these infections can be readily diagnosed and treated with currently available methods...
  3. ncbi Interferon-gamma expression in jejunal biopsies in experimental human cryptosporidiosis correlates with prior sensitization and control of oocyst excretion
    A C White
    Infectious Diseases Section, Dept of Medicine, Baylor College of Medicine, Houston, TX 77030
    J Infect Dis 181:701-9. 2000
    ..IFN-gamma production may explain the resistance to infection noted in sensitized persons but may not be involved in control of human primary infection...
  4. ncbi Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management
    A C White
    Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA
    Annu Rev Med 51:187-206. 2000
    ..The arachnoiditis may result in meningitis, vasculitis with stroke, or hydrocephalus. Patients should be treated with corticosteroids, antiparasitic drugs, and shunting if hydrocephalus is present...
  5. ncbi Expression of IL-15 and IL-4 in IFN-gamma-independent control of experimental human Cryptosporidium parvum infection
    P Robinson
    Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA
    Cytokine 15:39-46. 2001
    ..These data suggest that IL-15 is involved in IFN-gamma independent mechanisms of control of human cryptosporidiosis, perhaps via activation of the innate immune response...
  6. ncbi Determinants of sustained virological suppression in indigent, HIV-infected patients: is single protease inhibitor-based antiretroviral therapy truly highly active?
    F Visnegarwala
    Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA
    HIV Clin Trials 5:117-24. 2004
    ..Effective virological suppression with HAART is dependent on strict adherence to therapy. Compliance with therapy is influenced by clinical and psychosocial factors...
  7. ncbi Management of neurocysticercosis
    Terrence Riley
    Department of Neurology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA
    CNS Drugs 17:577-91. 2003
    ....
  8. ncbi Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoid
    W A Keitel
    Department of Microbiology and Immunology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
    Vaccine 18:531-9. 1999
    ..Both MSP-1(19) vaccines were immunogenic in humans, but changes in formulation will be necessary to improve safety and immunogenicity profiles...
  9. ncbi Is there a race-based disparity in the survival of veterans with HIV?
    Thomas P Giordano
    Department of Medicine, Baylor College of Medicine, Houston, TX, USA
    J Gen Intern Med 21:613-7. 2006
    ..Disparities in survival for black patients with HIV in the United States have been reported. The VA is an equal access health care system...
  10. ncbi ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results
    R L Murphy
    Department of Medicine, Northwestern University, Chicago, IL 60611, USA
    AIDS 15:F1-9. 2001
    ..The activity and durable suppression of HIV-1 observed in this study is probably attributable to the observed tolerability profile and the achievement of high ABT-378 plasma concentrations...
  11. ncbi Response of HIV-infected patients with asymptomatic syphilis to intensive intramuscular therapy with ceftriaxone or procaine penicillin
    N H Smith
    Infectious Disease Section, Department of Medicine, Baylor College of Medicine, One Baylor Plaza, 561E, Houston, Texas 77030, USA
    Int J STD AIDS 15:328-32. 2004
    ....